Live Breaking News & Updates on ப்ரிஸிஶந் துப்பாக்கி தொடர்|Page 8
Stay updated with breaking news from ப்ரிஸிஶந் துப்பாக்கி தொடர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SCIEX Acquires Intabio, a developer of precision solutions for biotherapeutic analysis through imaged cIEF-MS Innovative charged variant analysis accelerates biologic drug development, ensuring drug safety and efficacy SCIEX, a global leader in life science analytical technologies, announced the closing of its acquisition of Intabio, Inc., a privately held company and the developer of the Blaze System for biotherapeutic analysis and quality assessment. Blaze enables the direct coupling of imaged cIEF charge variant analysis with high-resolution mass spectrometry to detect intact proteins. Intabio s technology is an excellent fit with SCIEX. With our combined knowledge of the biopharma market, capillary electrophoresis and mass spectrometry, we believe we can significantly simplify how our customers bring life-saving drugs to market faster, said Inese Lowenstein, President at SCIEX. ....
Installation skills High-speed precision angular contact ball bearings are mainly used in high-speed rotation occasions with light loads. They require high precision, high speed, low temperature rise and low vibration and a certain service life. It is of ....
14 gennaio 2021 09:11 Fonte: Adnkronos #salute-e-benessere LEADING BIO-ENGINEERING AND MANUFACTURING SERVICES FIRM CATALYZES THE LAUNCH OF PRECISION S CELL AND GENE THERAPY OFFERING PRECISION ADVANCE ADDRESSING THE UNIQUE CHALLENGES OF CELL & GENE THERAPY INNOVATORS, FROM DEVELOPMENT THROUGH COMMERCIALIZATION BETHESDA, Md., Jan. 14, 2021 /PRNewswire/ Precision Medicine Group ( PMG ) announced today it has acquired Project Farma, a patient-focused bioengineering services firm that supports life science innovators in the manufacturing and scale-up of advanced therapies. Project Farma provides Precision a market-leading expertise in the manufacturing of life-changing medicines, with a unique focus in the rapidly growing area of cell and gene therapy. The acquisition adds Project Farma s unique expertise to Precision s suite of end-to-end cell and gene therapy capabilities to support development and commercialization. ....
Reportable, Inc.: Anticancer Bioscience Presenting at Biotech Showcase Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Anticancer Bioscience is participating in Biotech Showcase Digital 2021. The Company will showcase its pioneering approach to precision oncology, and how it is applying its synthetic lethality expertise for better cancer therapies. The Company has five distinct synthetic lethality programs in drug development. Click image above to view full announcement. About Anticancer Bioscience - https://www.anticancerbio.com/ Anticancer Bioscience (ACB) is an international private company, commercialising discoveries emerging from China s world-leading cancer research at the J. Michael Bishop Institute of Cancer Research. Pioneers in synthetic lethal approaches to precision o ....
(2) uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis aid pathologists in providing faster, more accurate patient diagnoses in breast cancer In combination with the VENTANA DP 200 slide scanner and Roche uPath enterprise software, the new algorithms provide innovative digital pathology solutions to advance personalised healthcare Nearly 2.1 million new cases of breast cancer are diagnosed worldwide each year. About 15 to 20 percent of women diagnosed with breast cancer are HER2 positive Basel, 11 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient. The image analysis algorithms use artificial intelligence to support pathologists in making faster, more accurate patient diagnoses in breast cancer. ....